PMID- 32283599 OWN - NLM STAT- MEDLINE DCOM- 20201231 LR - 20201231 IS - 1648-9144 (Electronic) IS - 1010-660X (Print) IS - 1010-660X (Linking) VI - 56 IP - 4 DP - 2020 Apr 9 TI - Identification of Cardiac MRI and Bio-Marker Thresholds for One-Year Survival in Pre-Capillary Pulmonary Hypertension: Prospective Study. LID - 10.3390/medicina56040167 [doi] LID - 167 AB - Background and objectives: Non-invasive imaging of the heart has an important place in the diagnosis and management of pulmonary arterial hypertension (PAH). The aim of this study was to establish the thresholds of cardiac magnetic resonance imaging (CMRI)-derived biventricular deformation, function parameters, and levels of N-terminal pro brain natriuretic peptide (NT-proBNP) for the prediction of survival of pre-capillary pulmonary hypertension (PHprecap) patients. Materials and Methods: In total, 64 incident PHprecap cases, who underwent CMRI, were consecutively enrolled in a prospective cohort study. Patients underwent a systemic evaluation, including measurement of NT-proBNP, two-dimensional (2D) echocardiography, six-minute walk test (6MWT), CMRI with feature tracking (FT), and right-heart catheterization (RHC). Patients were divided into two groups according to one-year survival (survival and non-survival groups). Survival analysis was performed. Results: One-year survival was 79.6%. The distribution between age, sex, mean pulmonary artery pressure (mPAP), New York Heart Association (NYHA) functional class, and 6MWT did not differ between the groups. Survival was significantly lower in the PAH group associated with connective tissue disease (CTD-PAH), where 44% (n = 4) of patients died during the first year. Univariate analysis revealed that severely reduced right-ventricle (RV) ejection fraction (EF) <25.5%, left-ventricle global longitudinal strain (LV GLS) >-14.18%, and right pulmonary artery (RPA) relative area change (RAC) <19%, and severely increased NT-proBNP level >1738 (ng/L) indicate an increased risk of death in PH(precap) patients. Conclusions: Impaired RV systolic function and LV global longitudinal strain, decrease of pulmonary artery distensibility, and CTD-PAH etiology, together with high NT-proBNP level, impair prognosis in pre-capillary PH patients. These findings are important for the risk stratification and management of pre-capillary pulmonary hypertension patients. FAU - Padervinskiene, Lina AU - Padervinskiene L AUID- ORCID: 0000-0003-3020-2810 AD - Department of Radiology, Medical Academy, Lithuanian University of Health Sciences, LT 44307 Kaunas, Lithuania. FAU - Hoppenot, Deimante AU - Hoppenot D AD - Department of Pulmonology, Medical Academy, Lithuanian University of Health Sciences, LT 44307 Kaunas, Lithuania. FAU - Krivickiene, Ausra AU - Krivickiene A AD - Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, LT 44307 Kaunas, Lithuania. FAU - Gumauskiene, Birute AU - Gumauskiene B AD - Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, LT 44307 Kaunas, Lithuania. FAU - Nedzelskiene, Irena AU - Nedzelskiene I AD - Department of Dental and Oral Diseases, Medical Academy, Lithuanian University of Health Sciences, LT 44307 Kaunas, Lithuania. FAU - Simkus, Paulius AU - Simkus P AD - Department of Radiology, Medical Academy, Lithuanian University of Health Sciences, LT 44307 Kaunas, Lithuania. FAU - Miliauskas, Skaidrius AU - Miliauskas S AD - Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, LT 44307 Kaunas, Lithuania. FAU - Jankauskas, Antanas AU - Jankauskas A AD - Department of Radiology, Medical Academy, Lithuanian University of Health Sciences, LT 44307 Kaunas, Lithuania. FAU - Basevicius, Algidas AU - Basevicius A AD - Department of Radiology, Medical Academy, Lithuanian University of Health Sciences, LT 44307 Kaunas, Lithuania. FAU - Ereminiene, Egle AU - Ereminiene E AD - Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, LT 44307 Kaunas, Lithuania. LA - eng PT - Journal Article DEP - 20200409 PL - Switzerland TA - Medicina (Kaunas) JT - Medicina (Kaunas, Lithuania) JID - 9425208 RN - 0 (Biomarkers) RN - 0 (Peptide Fragments) RN - 0 (pro-brain natriuretic peptide (1-76)) RN - 114471-18-0 (Natriuretic Peptide, Brain) RN - AU0V1LM3JT (Gadolinium) SB - IM MH - Aged MH - Biomarkers/*analysis MH - Chi-Square Distribution MH - Cohort Studies MH - Female MH - Gadolinium/therapeutic use MH - Humans MH - Hypertension, Pulmonary/blood/*complications MH - Magnetic Resonance Imaging/methods MH - Male MH - Middle Aged MH - Natriuretic Peptide, Brain/analysis/blood MH - Peptide Fragments/analysis/blood MH - Prognosis MH - Prospective Studies MH - Pulmonary Artery/*abnormalities/physiopathology MH - Survival Analysis MH - Weights and Measures/instrumentation PMC - PMC7230686 OTO - NOTNLM OT - cardiac magnetic resonance OT - feature tracking OT - pulmonary hypertension OT - right ventricle COIS- All authors declare that they have no competing interests. EDAT- 2020/04/15 06:00 MHDA- 2021/01/01 06:00 PMCR- 2020/04/09 CRDT- 2020/04/15 06:00 PHST- 2020/03/02 00:00 [received] PHST- 2020/03/23 00:00 [revised] PHST- 2020/04/07 00:00 [accepted] PHST- 2020/04/15 06:00 [entrez] PHST- 2020/04/15 06:00 [pubmed] PHST- 2021/01/01 06:00 [medline] PHST- 2020/04/09 00:00 [pmc-release] AID - medicina56040167 [pii] AID - medicina-56-00167 [pii] AID - 10.3390/medicina56040167 [doi] PST - epublish SO - Medicina (Kaunas). 2020 Apr 9;56(4):167. doi: 10.3390/medicina56040167.